Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Diagnosis and management of α1-antitrypsin deficiency in Europe: an expert survey.

Horváth I, Canotilho M, Chlumský J, Chorostowska-Wynimko J, Corda L, Derom E, Ficker JH, Kneussl M, Miravitlles M, Sucena M, Thabut G, Turner AM, van 't Wout E, McElvaney NG.

ERJ Open Res. 2019 Mar 11;5(1). pii: 00171-2018. doi: 10.1183/23120541.00171-2018. eCollection 2019 Feb.

2.

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency.

Miravitlles M, Chorostowska-Wynimko J, Ferrarotti I, McElvaney NG, O'Hara K, Stolk J, Stockley RA, Turner A, Wilkens M, Greulich T; EARCO Clinical Research Collaboration; Members of the EARCO Clinical Research Collaboration.

Eur Respir J. 2019 Feb 14;53(2). pii: 1900138. doi: 10.1183/13993003.00138-2019. Print 2019 Feb. No abstract available.

PMID:
30765486
3.

Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases.

Valiulis A, Bousquet J, Veryga A, Suprun U, Sergeenko D, Cebotari S, Borelli D, Pietikainen S, Banys J, Agache I, Billo NE, Bush A, Chkhaidze I, Dubey L, Fokkens WJ, Grigg J, Haahtela T, Julge K, Katilov O, Khaltaev N, Odemyr M, Palkonen S, Savli R, Utkus A, Vilc V, Alasevicius T, Bedbrook A, Bewick M, Chorostowska-Wynimko J, Danila E, Hadjipanayis A, Karseladze R, Kvedariene V, Lesinskas E, Münter L, Samolinski B, Sargsyan S, Sitkauskiene B, Somekh D, Vaideliene L, Valiulis A, Hellings PW.

Clin Transl Allergy. 2019 Jan 28;9:7. doi: 10.1186/s13601-019-0242-2. eCollection 2019. Review.

4.

Safety of biweekly α1-antitrypsin treatment in the RAPID programme.

Greulich T, Chlumsky J, Wencker M, Vit O, Fries M, Chung T, Shebl A, Vogelmeier C, Chapman KR, McElvaney NG; RAPID Trial Group.

Eur Respir J. 2018 Nov 29;52(5). pii: 1800897. doi: 10.1183/13993003.00897-2018. Print 2018 Nov. No abstract available.

PMID:
30237305
5.

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?

P W, P K, J CW, K R, K D, B MB, J P, K WK, G C, R R, M S, A G Ph.D, T O, T G, M P, K RŚ, J M.

Balkan J Med Genet. 2017 Dec 29;20(2):89-90. doi: 10.1515/bjmg-2017-0029. eCollection 2017 Dec. No abstract available.

6.

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.

Janciauskiene S, Wrenger S, Immenschuh S, Olejnicka B, Greulich T, Welte T, Chorostowska-Wynimko J.

Front Pharmacol. 2018 Apr 17;9:341. doi: 10.3389/fphar.2018.00341. eCollection 2018. Review.

7.

Interleukin 27 in bronchoalveolar lavage fluid in patients with non- small cell lung cancer. Authors' reply.

Kopiński P, Wandtke T, Wędrowska E, Chorostowska-Wynimko J.

Pol Arch Intern Med. 2018 Apr 30;128(4):266-268. doi: 10.20452/pamw.4258. Epub 2018 Apr 27. No abstract available.

8.

SERPINA1 Gene Variants in Granulomatosis with Polyangiitis.

Hadzik-Blaszczyk M, Zdral A, Zielonka TM, Rozy A, Krupa R, Falkowski A, Wardyn KA, Chorostowska-Wynimko J, Zycinska K.

Adv Exp Med Biol. 2018;1070:9-18. doi: 10.1007/5584_2018_156.

PMID:
29460271
9.

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.

Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 31;13:419-432. doi: 10.2147/COPD.S149429. eCollection 2018. Review.

10.

Pulmonary langerhans cell histiocytosis - insight into the incidence of alfa-1-antitrypsin (A1ATD) deficiency alleles.

Radzikowska E, Struniawski R, Chorostowska-Wynimko J, Wiatr E, Roszkowski-Śliż K.

Adv Respir Med. 2017;85(6):297-300. doi: 10.5603/ARM.2017.0051.

11.

Increased levels of interleukin 27 in patients with early clinical stages of non-small cell lung cancer.

Kopiński P, Wandtke T, Dyczek A, Wędrowska E, Roży A, Senderek T, Przybylski G, Chorostowska-Wynimko J.

Pol Arch Intern Med. 2018 Feb 28;128(2):105-114. doi: 10.20452/pamw.4156. Epub 2017 Nov 29.

12.

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

Ramlau R, Krawczyk P, Dziadziuszko R, Chmielewska I, Milanowski J, Olszewski W, Stencel K, Ramlau-Piątek K, Segiet A, Skroński M, Grudny J, Chorostowska-Wynimko J.

Oncol Lett. 2017 Nov;14(5):5611-5618. doi: 10.3892/ol.2017.6907. Epub 2017 Sep 7.

13.

Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study.

Radzikowska E, Wiatr E, Langfort R, Bestry I, Skoczylas A, Szczepulska-Wójcik E, Gawryluk D, Rudziński P, Chorostowska-Wynimko J, Roszkowski-Śliż K.

PLoS One. 2017 Sep 25;12(9):e0184739. doi: 10.1371/journal.pone.0184739. eCollection 2017.

14.

Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.

Janciauskiene S, Tumpara S, Wiese M, Wrenger S, Vijayan V, Gueler F, Chen R, Madyaningrana K, Mahadeva R, Welte T, Immenschuh S, Chorostowska-Wynimko J.

J Leukoc Biol. 2017 Oct;102(4):1127-1141. doi: 10.1189/jlb.3A0317-124R. Epub 2017 Jul 17.

PMID:
28716864
15.

Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.

Tortorici MA, Rogers JA, Vit O, Bexon M, Sandhaus RA, Burdon J, Chorostowska-Wynimko J, Thompson P, Stocks J, McElvaney NG, Chapman KR, Edelman JM.

Br J Clin Pharmacol. 2017 Nov;83(11):2386-2397. doi: 10.1111/bcp.13358. Epub 2017 Aug 11.

16.

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?

Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A, Welte T, Janciauskiene S.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 8;12:829-837. doi: 10.2147/COPD.S125240. eCollection 2017.

17.

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Florczuk M, Szpechcinski A, Chorostowska-Wynimko J.

Target Oncol. 2017 Apr;12(2):179-200. doi: 10.1007/s11523-017-0478-5. Review.

PMID:
28243959
18.

Clarithromycin Decreases IL-6 Concentration in Serum and BAL Fluid in Patients with Cryptogenic Organizing Pneumonia.

Radzikowska E, Roży A, Jagus P, Polubiec-Kownacka M, Wiatr E, Chorostowska-Wynimko J, Roszkowski-Śliż K.

Adv Clin Exp Med. 2016 Sep-Oct;25(5):871-878. doi: 10.17219/acem/61953.

19.

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).

McElvaney NG, Burdon J, Holmes M, Glanville A, Wark PA, Thompson PJ, Hernandez P, Chlumsky J, Teschler H, Ficker JH, Seersholm N, Altraja A, Mäkitaro R, Chorostowska-Wynimko J, Sanak M, Stoicescu PI, Piitulainen E, Vit O, Wencker M, Tortorici MA, Fries M, Edelman JM, Chapman KR; RAPID Extension Trial Group.

Lancet Respir Med. 2017 Jan;5(1):51-60. doi: 10.1016/S2213-2600(16)30430-1. Epub 2016 Dec 2. Erratum in: Lancet Respir Med. 2017 Feb;5(2):e13.

PMID:
27916480
20.

Standards for diagnosis and care of patients with inherited alpha-1 antitrypsin deficiency Recommendations of the Polish Respiratory Society, Polish Society of Pediatric Pulmonology and Polish Society of Pediatric Gastroenterology.

Chorostowska-Wynimko J, Bakuła A, Kulus M, Kuca P, Niżankowska-Mogilnicka E, Sanak M, Socha P, Śliwiński P.

Pneumonol Alergol Pol. 2016;84(3):193-202. doi: 10.5603/PiAP.2016.0023. No abstract available.

21.

Disease Modification in Emphysema Related to Alpha-1 Antitrypsin Deficiency.

Chorostowska-Wynimko J.

COPD. 2016 Dec;13(6):807-815. Epub 2016 May 12. Review.

PMID:
27172295
22.

Effectiveness of PCR and Immunofluorescence Techniques for Detecting Human Cytomegalovirus in Blood and Bronchoalveolar Lavage Fluid.

Roży A, Duk K, Szumna B, Skrońska P, Gawryluk D, Chorostowska-Wynimko J.

Adv Exp Med Biol. 2016;921:21-6. doi: 10.1007/5584_2016_246.

PMID:
27161108
23.

Frequency of Rare Alpha-1 Antitrypsin Variants in Polish Patients with Chronic Respiratory Disorders.

Duk K, Zdral A, Szumna B, Roży A, Chorostowska-Wynimko J.

Adv Exp Med Biol. 2016;910:47-53. doi: 10.1007/5584_2016_213.

PMID:
26987331
24.

Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment.

Radzikowska E, Roży A, Jaguś P, Wiatr E, Gawryluk D, Chorostowska-Wynimko J, Roszkowski-Śliż K.

Adv Exp Med Biol. 2016;911:77-85. doi: 10.1007/5584_2016_223.

PMID:
26987326
25.

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators.

N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.

26.

Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.

Szpechcinski A, Rudzinski P, Kupis W, Langfort R, Orlowski T, Chorostowska-Wynimko J.

Cancer Lett. 2016 May 1;374(2):202-7. doi: 10.1016/j.canlet.2016.02.002. Epub 2016 Feb 5.

PMID:
26854716
27.

[Programmed necrosis and necroptosis - molecular mechanisms].

Giżycka A, Chorostowska-Wynimko J.

Postepy Hig Med Dosw (Online). 2015 Dec 16;69:1353-63. Review. Polish.

28.

Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Wozniak J, Wandtke T, Kopinski P, Chorostowska-Wynimko J.

Hum Gene Ther. 2015 Nov;26(11):709-18. doi: 10.1089/hum.2015.044. Epub 2015 Sep 29. Review.

29.

Coexistence of Borrelia burgdorferi s.l. genospecies within Ixodes ricinus ticks from central and eastern Poland.

Sytykiewicz H, Karbowiak G, Chorostowska-Wynimko J, Szpechciński A, Supergan-Marwicz M, Horbowicz M, Szwed M, Czerniewicz P, Sprawka I.

Acta Parasitol. 2015 Dec;60(4):654-61. doi: 10.1515/ap-2015-0093.

PMID:
26408587
30.

Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis.

Radzikowska E, Jaguś P, Sobiecka M, Chorostowska-Wynimko J, Wiatr E, Kuś J, Roszkowski-Śliż K.

Respir Med. 2015 Nov;109(11):1469-75. doi: 10.1016/j.rmed.2015.09.005. Epub 2015 Sep 12.

31.

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

Ferrarotti I, Poplawska-Wisniewska B, Trevisan MT, Koepke J, Dresel M, Koczulla R, Ottaviani S, Baldo R, Gorrini M, Sala G, Cavallon L, Welte T, Chorostowska-Wynimko J, Luisetti M, Janciauskiene S.

PLoS One. 2015 Aug 13;10(8):e0135316. doi: 10.1371/journal.pone.0135316. eCollection 2015.

32.

The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.

Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM; European COPD Audit team.

PLoS One. 2015 Jul 27;10(7):e0134004. doi: 10.1371/journal.pone.0134004. eCollection 2015.

33.

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.

Szpechcinski A, Chorostowska-Wynimko J, Struniawski R, Kupis W, Rudzinski P, Langfort R, Puscinska E, Bielen P, Sliwinski P, Orlowski T.

Br J Cancer. 2015 Jul 28;113(3):476-83. doi: 10.1038/bjc.2015.225. Epub 2015 Jun 30.

34.

The national alpha-1 antitrypsin deficiency registry in Poland.

Chorostowska-Wynimko J, Struniawski R, Sliwinski P, Wajda B, Czajkowska-Malinowska M.

COPD. 2015 May;12 Suppl 1:22-6. doi: 10.3109/15412555.2015.1021915.

PMID:
25938287
35.

Lung cancer: our blood, sweat and fears.

Chorostowska-Wynimko J.

Pneumonol Alergol Pol. 2015;83(2):98-100. doi: 10.5603/PiAP.2015.0016. No abstract available.

36.

Targeted screening programmes in COPD: how to identify individuals with α1-antitrypsin deficiency.

Chorostowska-Wynimko J.

Eur Respir Rev. 2015 Mar;24(135):40-5. doi: 10.1183/09059180.00010614. Review.

37.

Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases.

Przybylski G, Chorostowska-Wynimko J, Dyczek A, Wędrowska E, Jankowski M, Szpechciński A, Giżycka A, Golińska J, Kopiński P.

Pol Arch Med Wewn. 2015;125(4):260-71. Epub 2015 Feb 20. Erratum in: Pol Arch Med Wewn. 2015;125(6):482-3.

38.

Alpha-1 antitrypsin deficiency, SZ phenotype: a rare type of a rare disease. Case report.

Nebunoiu AM, Deleanu OC, Rohan I, Mihălţan F, Chorostowska-Wynimko J, Ulmeanu R.

Pneumologia. 2014 Oct-Dec;63(4):218-23.

PMID:
25665366
39.

[Programmed cell death: is it only apoptosis?].

Kopiński P, Gizycka A, Chorostowska-Wynimko J.

Pol Merkur Lekarski. 2014 Oct;37(220):201-5. Polish.

PMID:
25518573
40.

Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.

Krawczyk P, Chorostowska-Wynimko J, Dziadziuszko R, Jassem J, Krzakowski M, Langfort R, Puacz E, Wasąg B, Wojas-Krawczyk K.

Pneumonol Alergol Pol. 2014;82(5):437-44. doi: 10.5603/PiAP.2014.0057.

41.

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study.

Krawczyk P, Ramlau R, Chorostowska-Wynimko J, Powrózek T, Lewandowska MA, Limon J, Wasąg B, Pankowski J, Kozielski J, Kalinka-Warzocha E, Szczęsna A, Wojas-Krawczyk K, Skroński M, Dziadziuszko R, Jaguś P, Antoszewska E, Szumiło J, Jarosz B, Woźniak A, Jóźwicki W, Dyszkiewicz W, Pasieka-Lis M, Kowalski DM, Krzakowski M, Jassem J, Milanowski J.

J Cancer Res Clin Oncol. 2015 Jan;141(1):61-8. doi: 10.1007/s00432-014-1789-x. Epub 2014 Aug 3.

42.

[Current methods to detect EGFR gene mutations as predictive factor for targeted therapies in non-small cell lung cancer - is there a "golden standard" in diagnostics?].

Skroński M, Szpechciński A, Chorostowska-Wynimko J.

Pneumonol Alergol Pol. 2014;82(3):311-22. doi: 10.5603/PiAP.2014.0036. Review. Polish.

43.

[Apoptosis of alveolar lymphocytes. Part 1: pathways of lymphocyte apoptosis].

Kopiński P, Chorostowska-Wynimko J, Dyczek A, Giżycka A.

Pneumonol Alergol Pol. 2014;82(2):170-82. doi: 10.5603/PiAP.2014.0023. Review. Polish.

44.

[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].

Jassem J, Biernat W, Bryl M, Chorostowska-Wynimko J, Dziadziuszko R, Krawczyk P, Kordek R, Kowalski DM, Krzakowski M, Olszewski W, Orłowski T, Ramlau R, Rzyman W.

Pneumonol Alergol Pol. 2014;82(2):133-49. doi: 10.5603/PiAP.2014.0019. Review. Polish.

45.

Role of serum vascular endothelial growth factor D in discrimination of patients with polycystic lung diseases.

Radzikowska E, Jaguś P, Skoczylas A, Sobiecka M, Chorostowska-Wynimko J, Wiatr E, Kuś J, Roszkowski-Śliż K.

Pol Arch Med Wewn. 2013;123(10):533-8. Epub 2013 Sep 24.

46.

Variability of hospital resources for acute care of COPD patients: the European COPD Audit.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

Eur Respir J. 2014 Mar;43(3):754-62. doi: 10.1183/09031936.00074413. Epub 2013 Aug 29.

47.

[Believe in miracles--Central-Eastern European Alpha-1 Antitrypsin Network].

Chorostowska-Wynimko J.

Pneumonol Alergol Pol. 2013;81(4):285-7. Polish. No abstract available.

48.

Incidence of alpha-1 antitrypsin Z and S alleles in patients with granulomatosis with polyangiitis--pilot study.

Chorostowska-Wynimko J, Gawryluk D, Struniawski R, Popławska B, Fijołek J.

Pneumonol Alergol Pol. 2013;81(4):319-22.

49.

European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions.

Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S; European COPD Audit team.

Thorax. 2013 Dec;68(12):1169-71. doi: 10.1136/thoraxjnl-2013-203465. Epub 2013 Jun 1.

PMID:
23729193
50.

[Higher incidence of alveolar lymphocytes (AL) apoptosis in smokers depends on BCL-2 expression and specific response to tumor necrosis factor alpha (TNFalpha). Bronchoalveolar lavage (BAL) material analysis from selected interstitial lung diseases (ILD) and healthy controls].

Kopiński P, Dyczek A, Chorostowska-Wynimko J, Marszałek A, Balicka-Slusarczyk B, Kubiszewska I, Szabłowska K, Półgesek E, Szpechciński A.

Przegl Lek. 2012;69(10):731-6. Polish.

PMID:
23421021

Supplemental Content

Loading ...
Support Center